Center-Authored Papers

Filters: Author is Chamberlain, Marc C  [Clear All Filters]
Journal Article
Chamberlain MC, Goulart BHL.  2013.  Are prognostic factors for leptomeningeal metastases defined sufficiently to permit tailored treatment? Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 8(7):e66-7.
Chamberlain MC.  2008.  Bevacizumab plus irinotecan in recurrent glioblastoma.. Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 26(6):1012-3;authorreply1013.
Grimm SA, Chamberlain MC.  2013.  Brainstem glioma: a review.. Current neurology and neuroscience reports. 13(5):346. Abstract
Brem SS, Bierman PJ, Brem H, Butowski N, Chamberlain MC, Chiocca EA, DeAngelis LM, Fenstermaker RA, Friedman A, Gilbert MR et al..  2011.  Central nervous system cancers.. Journal of the National Comprehensive Cancer Network : JNCCN. 9(4):352-400.
Taillibert S, Le Rhun E, Chamberlain MC.  2016.  Chemotherapy-Related Neurotoxicity.. Current neurology and neuroscience reports. 16(9):81. Abstract
Holdhoff M, Chamberlain MC.  2013.  Controversies in the treatment of elderly patients with newly diagnosed glioblastoma.. Journal of the National Comprehensive Cancer Network : JNCCN. 11(9):1165-72;quiz1173. Abstract
Chamberlain MC.  2015.  Does Hippocampal-Avoidance Whole-Brain Radiotherapy for Brain Metastases Meaningfully Change Current Practice? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 33(17):1985.
Chamberlain MC.  2013.  Does quality of life supplant survival in patients with brain metastasis? Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 31(20):2635.